BASF filed a lawsuit against Willowood's infringement on its fungicide pyraclostrobin

Date:02-12-2018

BASF has filed a lawsuit against Willowood LLC to halt the ongoing infringement of certain BASF patents relating to the manufacture and use of its fungicide pyraclostrobin.

BASF has led the way in the research and development (R&D) of active ingredients like pyraclostrobin that control fungal diseases and offer plant health benefits. BASF is committed to investing in the research and development of new and innovative products and protecting the Intellectual Property, which results from this development. Each new active ingredient represents an investment of more than $250 million in the agricultural industry and ensures growers have cutting edge tools to manage their crops and ultimately support the food demands of a growing global population.

“Farmers rely on innovation from partners like BASF to help improve the yield and quality of their crop,” said Senior Vice President, BASF North America, Paul Rea. “BASF remains at the forefront of crop protection product development and innovation, bringing new solutions to growers.”

BASF has a broad portfolio of patents surrounding pyraclostrobin-containing products, mixtures and intermediates in the United States and globally. Pyraclostrobin is the key ingredient in BASF plant health fungicides, and is approved by the US EPA for controlling a broad range of diseases and improving plant health, which can result in improvements in crop growth and quality. These products include Headline SC, Headline, Headline AMP, Priaxor, Pristine, Merivon, Twinline, Nexicor, Cabrio, Insignia, and Xanthion fungicides, Stamina F3, and Stamina F4 Cereals fungicide seed treatments.

“Growers using BASF fungicides can be confident that the products are manufactured to the highest quality standards and will continue to perform reliably,” added Rea. “We expect continued growth for our pyraclostrobin-based products and mixtures, as they have proven to be highly effective and reliable fungicides due to proprietary, high-quality R&D and formulation expertise.”

To continue the significant investments in the research and development of new compounds, BASF will protect the investments already made through its legally enforceable intellectual property rights.